FDA Issues MedWatch on Biogen Idec's Amevive

Drug Industry Daily
KEYWORDS FDA
A A

Biogen Idec’s psoriasis treatment Amevive may cause complications in patients with HIV, according to a Nov. 10 MedWatch alert.

To View This Article:

Login

Subscribe To Drug Industry Daily